macro

Wells Fargo Keeps Equal-Weight on TPG and Alnylam, Changes Price Targets

Wells Fargo kept equal-weight ratings on TPG and Alnylam Pharmaceuticals, raising the TPG target to $52 and cutting Alnylam's to $220.

the same feed is available to bots and dashboards through the api. connect the api →

what happened

Wells Fargo analysts kept their equal-weight ratings on TPG and Alnylam Pharmaceuticals, according to Dow Jones Newswires, which cited Benzinga data. An equal-weight rating suggests the bank expects the shares to perform roughly in line with the broader market.

The bank lifted its price target on TPG to $52 a share from $47. For Alnylam Pharmaceuticals, it reduced the target to $220 from $253 a share.

why it matters

Analyst moves on individual stocks mainly matter to investors in those companies. The unchanged ratings alongside revised targets point to a shift in valuation expectations rather than a change in the bank's overall view, so the effect on the wider market is limited.

tags

instruments

TPGAlnylam Pharmaceuticals

sources

  1. TPG Is Maintained at Equal-Weight by Wells Fargo — Dow Jones Newswires, 30 October 2026 at 16:38 UTC
  2. Alnylam Pharmaceuticals Is Maintained at Equal-Weight by Wells Fargo — Dow Jones Newswires, 30 October 2026 at 16:52 UTC
  3. Schneider National Is Maintained at Equal-Weight by Wells Fargo — Dow Jones Newswires, 30 October 2026 at 18:21 UTC
  4. Saia Is Maintained at Equal-Weight by Wells Fargo — Dow Jones Newswires, 30 October 2026 at 18:20 UTC
  5. CSW Industrials Is Maintained at Equal-Weight by Wells Fargo — Dow Jones Newswires, 30 October 2026 at 18:15 UTC
  6. Amrize Is Maintained at Equal-Weight by Wells Fargo — Dow Jones Newswires, 30 October 2026 at 18:24 UTC
  7. Tenable Holdings Is Maintained at Equal-Weight by Wells Fargo — Dow Jones Newswires, 30 October 2026 at 18:48 UTC
  8. Sandisk Is Maintained at Equal-Weight by Wells Fargo — Dow Jones Newswires, 30 October 2026 at 18:53 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗